Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01101360 · ClinicalTrials.gov registry record · NA

Port Wine Stains Treatment Matrix RF Study

A NA study, sponsored by Syneron Medical.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01101360 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01101360, a NA study, has completed, sponsored by Syneron Medical.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy and safety of the Matrix RF for Port Wine Stains based on clinical and histological analyses.

Interventions

  • DEVICE Matrix RF
  • DEVICE Matrix RF followed by Pulse Dye Laser
  • DEVICE Pulse Dye Laser followed by Matrix RF

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-03
Phase NA

Sponsor

Syneron Medical

18 total trials

What the Registry Record Tells You About NCT01101360

The ClinicalTrials.gov registry entry for NCT01101360 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Matrix RF is the first listed.

NCT01101360 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01101360 about?

NCT01101360 is a clinical study titled "Port Wine Stains Treatment Matrix RF Study". The purpose of this study is to evaluate the efficacy and safety of the Matrix RF for Port Wine Stains based on clinical and histological analyses.

What is the current status of trial NCT01101360?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-03.

What interventions are being tested in trial NCT01101360?

The interventions under investigation include: Matrix RF (DEVICE), Matrix RF followed by Pulse Dye Laser (DEVICE), Pulse Dye Laser followed by Matrix RF (DEVICE).

Who is sponsoring clinical trial NCT01101360?

This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.